Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study

The aims of this multicentre, randomised phase III trial were to evaluate: (1) the role of levamisol (LEV); and (2) the role of folinic acid (FA), added to 5-fluorouracil (5FU) in the adjuvant treatment of colorectal cancer. Patients with histologically proven, radically resected stage II or III col...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: De Placido, S, Lopez, M, Carlomagno, C, Paoletti, G, Palazzo, S, Manzione, L, Iannace, C, Ianniello, G P, De Vita, F, Ficorella, C, Farris, A, Pistillucci, G, Gemini, M, Cortesi, E, Adamo, V, Gebbia, N, Palmeri, S, Gallo, C, Perrone, F, Persico, G, Bianco, A R
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2005
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361663/
https://ncbi.nlm.nih.gov/pubmed/16222322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602800
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars